summary
Introduced
09/03/2019
09/03/2019
In Committee
Crossed Over
Passed
Dead
03/19/2020
03/19/2020
Introduced Session
2020 Regular Session
Bill Summary
An act relating to prescription insulin drugs; creating ss. 627.64085 and 627.65746, F.S.; defining the term "prescription insulin drug"; requiring individual and group health insurance policies, respectively, to cap an insured's monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount; providing construction; authorizing the Financial Services Commission to adopt rules; amending s. 641.31, F.S.; defining the term "prescription insulin drug"; requiring health maintenance contracts to cap a subscriber's monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount; providing construction; authorizing the commission to adopt rules; providing an effective date.
AI Summary
This bill creates new sections of Florida statutes to cap the monthly cost-sharing obligation for insured individuals and group health plan members at $100 per 30-day supply of prescription insulin drugs, regardless of the amount or type of insulin needed. The bill defines "prescription insulin drug" as a prescription drug containing insulin, used to treat diabetes, and prescribed as medically necessary by a physician. The bill authorizes the Financial Services Commission to adopt rules to administer these new cost-sharing limits, and it takes effect on January 1, 2021.
Sponsors (1)
Last Action
Withdrawn prior to introduction (on 09/03/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.flsenate.gov/Session/Bill/2020/107 |
| Bill | https://www.flsenate.gov/Session/Bill/2020/107/BillText/Filed/PDF |
Loading...